Шрифт:
Интервал:
Закладка:
198
Nina Hamazaki-Fujita et al., “Polyunsaturated Fatty Acids and Blood Circulation in the Forebrain during a Mental Arithmetic Task,” Brain Research 1397 (June 23, 2011): 38–45.
199
Jennifer Mildenberger et al., “N-3 PUFAs Induce Inflammatory Tolerance by Formation of KEAP1-Containing SQSTM1/p62-Bodies and Activation of NFE2L2,” Autophagy 13, no. 10 (October 3, 2017): 1664-78.
200
Fredrik Jernerén et al., “Brain Atrophy in Cognitively Impaired Elderly: The Importance of Long-Chain ω-3 Fatty Acids and B Vitamin Status in a Randomized Controlled Trial,” American Journal of Clinical Nutrition 102, no. 1 (July 2015): 215-21.
201
Emma L. Wightman et al., “Epigallocatechin Gallate, Cerebral Blood Flow Parameters, Cognitive Performance and Mood in Healthy Humans: A Double-Blind, Placebo-Controlled, Crossover Investigation,” Human Psychopharmacology 27, no. 2 (March 2012): 177-86.
202
Xiaoli Peng et al., “Effect of Green Tea Consumption on Blood Pressure: A Meta-Analysis of 13 Randomized Controlled Trials,” Scientific Reports 4 (September 1, 2014): 6251.
203
Xin-Xin Zheng et al., “Green Tea Intake Lowers Fasting Serum Total and LDL Cholesterol in Adults: A Meta-Analysis of 14 Randomized Controlled Trials,” American Journal of Clinical Nutrition 94, no. 2 (August 2011): 601-10.
204
Xin-Xin Zheng et al., “Effects of Green Tea Catechins with or without Caffeine on Glycemic Control in Adults: A Meta-Analysis of Randomized Controlled Trials,” American Journal of Clinical Nutrition 97, no. 4 (April 2013): 750-62.
205
Qiangye Zhang et al., “Effect of Green Tea on Reward Learning in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Pilot Study,” Nutrition Journal 12, no. 84 (June 18, 2013).
206
Qing-Ping Ma et al., “Meta-Analysis of the Association between Tea Intake and the Risk of Cognitive Disorders,” PLoS One 11, no. 11 (November 8, 2016): e0165861. L. Feng et al., “Tea Consumption Reduces the Incidence of Neurocognitive Disorders: Findings from the Singapore Longitudinal Aging Study,” Journal of Nutrition, Health & Aging 20, no. 10 (2016): 1002-9.
207
David O. Kennedy et al., “Effects of Resveratrol on Cerebral Blood Flow Variables and Cognitive Performance in Humans: A Double-Blind, Placebo-Controlled, Crossover Investigation,” American Journal of Clinical Nutrition 91, no. 6 (June 2010): 1590-97. Rachel H. X. Wong et al., “Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus,” Nutrients 8, no. 7 (July 12, 2016): 425.
208
Daniel G. Amen et al., “Patterns of Regional Cerebral Blood Flow as a Function of Age throughout the Lifespan,” Journal of Alzheimer’s Disease 65, no. 4 (2018): 1087-92.
209
D. J. Hare et al., “Is Early-Life Iron Exposure Critical in Neurodegeneration?” Nature Reviews Neurology 11, no. 9 (September 2015): 536-44.
210
R. McClelland et al., “Accelerated Ageing and Renal Dysfunction Links Lower Socioeconomic Status and Dietary Phosphate Intake,” Aging 8, no. 5 (May 2016): 1135-49.
211
L. E. Hebert et al., “Change in Risk of Alzheimer Disease Over Time,” Neurology 75, no. 9 (August 31, 2010): 786-91.
212
“Mental Health of Older Adults,” World Health Organization, December 12, 2017, www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults.
213
W. Cai et al., “Oral Glycotoxins Are a Modifiable Cause of Dementia and the Metabolic Syndrome in Mice and Humans,” Proceedings of the National Academy of Sciences of the United States of America 111, no. 13 (April 1, 2014): 4940-45.
214
“National Poll on Healthy Aging,” University of Michigan (March 2019), ihpi.umich.edu/sites/default/files/2019-03/NPHA_Loneliness-Report_FINAL-022619.pdf.
215
Gabriel H. Sahlgren, “Work Longer, Live Healthier,” IEA discussion paper no. 46 (May 2013), http://iea.org.uk/sites/default/files/publications/files/Work%20Longer,%20Live_Healthier.pdf.
216
Kapil Sayal et al., “Relative Age within the School Year and Diagnosis of Attention-Deficit Hyperactivity Disorder: A Nationwide Population-Based Study,” Lancet Psychiatry 4, no. 11 (November 1, 2017): 868-75.
217
Corey L. M. Keyes, “Authentic Purpose: The Spiritual Infrastructure of Life,” Journal of Management, Spirituality & Religion 8, no. 4 (November 2011): 281-97.
218
P. A. Boyle, et al., “Effect of Purpose in Life on Risk of Incident Alzheimer Disease and Mild Cognitive Impairment in Community-Dwelling Older Persons,” Archives of General Psychiatry 67, no. 3 (March 2010): 304-10.
219
T. J. Holwerda et al., “Feelings of Loneliness, but Not Social Isolation, Predict Dementia Onset: Results from the Amsterdam Study of the Elderly (AMSTEL),” Journal of Neurology, Neurosurgery, and Psychiatry 85, no. 2 (February 2014): 135-42.
220
“Loneliness on the RISE: One in Eight People Have No Close Friends to Turn To,” Express, March 1, 2017, http://www.express.co.uk/news/uk/773002/One-in-eight-people-faced-with-loneliness.
221
Kira Asatryan, “4 Disorders That May Thrive on Loneliness,” Psychology Today, July 23, 2015, https://www.psychologytoday.com/us/blog/the-art-closeness/201507/4-disorders-may-thrive-loneliness.
222
E. E. Lee et al., “High Prevalence and Adverse Health Effects of Loneliness in Community-Dwelling Adults across the Lifespan: Role of Wisdom as a Protective Factor,” International Psychogeriatrics (published online December 18, 2018): 1-16.
223
S. Korkmaz et al., “Frequency of Anemia in Chronic Psychiatry Patients,” Neuropsychiatric Disease and Treatment 11 (October 22, 2015): 2737-41.
224
Joseph Mercola, “Iron: This Life-Saving Mineral Found to Actually Increase Senility in Many,” Mercola, July 19, 2012, http://articles.mercola.com/sites/articles/archive/2012/07/19/excess-iron-leads-to-alzheimers.aspx#_edn1. D. J. Hare et al., “Is Early-Life Iron Exposure Critical in Neurodegeneration?” A. C. Leskovjan et al., “Increased Brain Iron Coincides with Early Plaque Formation in a